About Chongqing Zhifei Biological Products

Chongqing Zhifei Biological Products Co., Ltd. engages in the wholesale of biological products and vaccines. Its main products are meningococcal group A&C conjugate vaccine, meningococcal polysaccharide vaccine, mycobacterium vaccae, Haemophilus Influenzae type b conjugate vaccine, and freeze-dried live attenuated hepatitis A vaccine. Its other activities are biotechnology research, development, and consulting; import and export, and storage services. The company was founded on July 20, 1995 and is headquartered in Chongqing, China.

Chongqing Zhifei Biological Products Company Stats
Industry
Drugs & Biotechnology
Founded
1995
Headquarters
Chongqing
Country/Territory
China
Chief Executive Officer
Ren Sheng Jiang
Employees
5,735

Forbes Lists

#1218

Chongqing Zhifei Biological Products Financial Summary

Select list year
2023
2022
2021
2020
Revenue
$5.9B
Assets
$6.3B
Profits
$1.1B
Sources
FactSet, Bloomberg, S&P Cap IQ; Forbes.
Related People & Companies
Covance
Covance
Related by Industry: Drugs & Biotechnology
View Profile

More on Forbes